689彩票邀请码

Redmile Group

COMPARE

Overview

Number of Exits 41
CB Rank (Investor) 878
Redmile Group
Healthcare investment organization that does venture, growth and crossover investing across healthcare.
Industries  Health Care, Hedge Funds, Venture CapitalHeadquarters Regions  San Francisco Bay Area, West Coast, Western USFounded Date 2007Operating Status ActiveNumber of Employees 11-50Child Hubs  Redmile Group Portfolio Companies
Investor Type  Hedge Fund, Private Equity Firm, Venture Capital Investment Stage  Debt, Early Stage Venture, Late Stage Venture, Post-Ipo, Private Equity Number of Exits 41
Website LinkedIn 

Unlock Charts on Crunchbase

Charts can be found on various organization profiles and on Hubs pages, based on data availability.

Lists Featuring This Company

Post IPO Investors with Investments in Greater Los Angeles Area
62 Number of Organizations ● $101M Total Funding Amount ● 11 Number of Investors
San Francisco Investors
1,535 Number of Organizations ● $65.3B Total Funding Amount ● 2,123 Number of Investors
Late Stage Venture Investors with Investments in Santa Rosa, California
51 Number of Organizations ● $80M Total Funding Amount ● 1 Number of Investors
Early Stage Venture Investors with Investments in Santa Rosa, California
56 Number of Organizations ● $93.5M Total Funding Amount ● 2 Number of Investors

Investments

Number of Investments 83
Number of Lead Investments 22
Redmile Group has made 83 investments. Their most recent investment was on Mar 12, 2020, when Nurix raised $120M.

Exits

Number of Exits 41
Redmile Group has had 41 exits. Redmile Group's most notable exits include InvitaeFoundation Medicine, and Blueprint Medicines.
Invitae
Reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information
Foundation Medicine
Foundation medicine is a molecular information company developing clinical diagnostic tests that facilitates personalized cancer therapies.
Blueprint Medicines
Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.
BioNTech
BioNTech is a biopharmaceutical company pioneering the development of individualized therapies for cancer and other diseases.
Audentes Therapeutics
Audentes is a biotechnology company that employs gene therapy technology to develop treatments for people with rare muscle diseases.
Redx Pharma
Redx Pharma is a drug discovery and development company.
Gritstone Oncology
Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types.
Wave Life Sciences
WaVe Life Sciences is leading the development of next-generation nucleic acids for therapeutic and diagnostic applications.
Atreca
Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.
CytomX Therapeutics
CytomX Therapeutics is an early-stage biotechnology company developing Probodies, proteolytically-activated antibodies.

Funds Raised

Number of Funds 6
Redmile Group has raised 6 funds, their latest being Redmile Biopharma Investments I. This fund was announced on Jul 27, 2018 and raised a total of $218.3M.
Announced Date  
Fund Name  
Money Raised  
Jul 27, 2018
Redmile Biopharma Investments I
$218.3M
Feb 14, 2018
Redmile Strategic Fund
$7.3M
Feb 14, 2018
Redmile Capital Fund
$440M
Mar 2, 2017
Redmile Private Investments I Affiliates
$28.7M
Dec 30, 2015
Redmile Private Investments II
$63.8M
May 20, 2013
Redmile Private Investments I

Current Team

Number of Current Team Members 4
Redmile Group has 4 current team members, including Managing Director Rob Faulkner.
Rob Faulkner
Managing Director
Joshua Sommerfeld
Vice President
Ming Fang
Vice President

Website Tech Stack by BuiltWith

Redmile Group is actively using 12 technologies for its website. These include Viewport MetaIPhone / Mobile Compatible, and Apache.

Web Traffic by SimilarWeb

Redmile Group is ranked 12,210,506 among websites globally based on its 659 monthly web visitors.

Interest Signals by Bombora

Redmile Group employees are showing high interest in Data ClassificationData Entry, and Data Consolidation.

IT Spend by Aberdeen

This year, Redmile Group is projected to spend $72.3K on IT.

Recent News & Activity

Number of Articles 8

Related Hubs

Sign up for a free Crunchbase account to follow and track profiles you care about.


|| Sitemap | ? 2020 Crunchbase Inc. All Rights Reserved. (2b5d7be 198)
7072彩票开户 7073彩票地址 689彩票邀请码 7073彩票网址 963彩票开户 8炫彩彩票app 7073彩票注册 677彩票开户 66顺彩票app 7073彩票登录